Colorectal Cancer Diagnostics Market Is Slated To Accelerate At A CAGR Of 5% To Top US$ 70 Bn By 2031

According to Fact.MR, a market research and competitive intelligence provider, the global colorectal cancer diagnostics market is anticipated to rise at a robust CAGR of 8.5% over the next ten years. As per this study, the market was valued at around US$ 2 Bn in 2020, and is anticipated to expand 2.2X by the end of the decade.

Incidence of colorectal cancer is increasing worldwide, and the World Health Organization (WHO) has predicted a rise of around 70% in cases by 2031. Increasing incidence of the disease can be attributed to factors such as poor lifestyle choices, unhealthy eating, aging, and diet-related disorders.

As colorectal cancer is mostly found in older adults, increasing geriatric population will also play a role in rising demand for effecting diagnostics. Increasing awareness, rising research & development on various diagnostic and treatment solutions, and introduction of effective diagnostic instruments are some of the factors that are expected to drive market expansion over the coming years.

As awareness increases in emerging and developing economies, these regions expected to see major demand for colorectal cancer diagnostics. The market in Asia Pacific is anticipated to witness the fastest growth in terms of CAGR.  North America is expected to hold a dominant market share through the decade.

Get Sample Copy With Impact Analysis Of COVID-19 Of Market Report –

Colorectal Cancer Diagnostics Market – Scope of Report:

A latest publication by Fact.MR on the global Colorectal Cancer Diagnostics market evaluates the opportunities and current market landscape, and provides detailed analysis and updates about corresponding sections affecting the market.

The study offers detailed insights on key market dynamics, which include the drivers, restraints, trends, and opportunities in the market.

The principal aim of the study is to present exclusive information about how the market will perform during the forecast period of 2020-2030.

Important indicators for the successful growth of the Colorectal Cancer Diagnostics market are presented in this comprehensive report, which include Year-on-Year (Y-o-Y) growth analysis of the market, and compounded annual growth rate (CAGR), which are described in an exhaustive way in Fact.MR’s study.

This research study can support readers to know the demand for Colorectal Cancer Diagnostics supplements, and the quantitative development opportunities during the study period.

The research is beneficial for shareholders in Pulse Oximeters, including investors, manufacturers, service providers, distributors, and suppliers, and can help them in developing suitable business strategies to flourish in the market.

Insights and wisdom presented in this Fact.MR study can be leveraged by shareholders in the market, industry experts, investors, researchers, and reporters, as well as business enthusiasts.

In-depth Analysis on Competitive Landscape

The report sheds light on leading providers of Colorectal Cancer Diagnostics, along with their detailed profiles. Essential and up-to-date data related to market performers who are principally engaged in the Colorectal Cancer Diagnostics offering has been brought with the help of a detailed dashboard view. Market share analysis and comparison of prominent players provided in the report permits report readers to take preemptive steps in advancing their businesses.

Company profiles have been included in the report, which include essentials such as product portfolios and key strategies, along with all-inclusive SWOT analysis on each player. Company presence is mapped and presented through a matrix for all the prominent players, thus providing readers with actionable insights, which helps in thoughtfully presenting the market status, and predicting the competition level in the Colorectal Cancer Diagnostics market.

Get Customization on this Report for Specific Research Solutions:-

Report benefits & key questions answered

  • Post covid consumer spending on Colorectal Cancer Diagnostics: the report also highlights the change in the buying behavior of consumers and shifts in purchasing power, post covid-19. This information will assist the businesses to plan their production and marketing strategies.
  • Colorectal Cancer Diagnostics demand outlook: the market intelligence study reports highlights the factor propelling the demand for Colorectal Cancer Diagnostics. As per the study, the demand for Colorectal Cancer Diagnostics will grow through 2031.
  • Colorectal Cancer Diagnostics historical volume analysis: Fact.MR survey report provides insights into the sales registered over the last forecast year 2016 to 2020 and create estimates regarding the sales performance for 2021-2031.
  • Colorectal Cancer Diagnostics consumption by demographics: the report provides consumption by demographics analysis to assist the market players in designing their expansion strategies on the basis of consumption pattern of the customers.

Colorectal Cancer Diagnostics Market Segmentations:

  • By Test Type:
    • Colorectal Cancer FOB Tests
    • Colorectal Cancer CTC Tests
    • Colorectal Cancer CEA Tests
    • Colorectal Cancer BRAF V600 Mutation Tests
    • Colorectal Cancer Immunohistochemistry Tests
    • C-kit/CD117
    • KRAS Mutation Tests
    • Others
  • By End User:
    • Hospital-associated Labs
    • Independent Diagnostic Laboratories
    • Cancer Research Institutes
    • Others

For in-depth competitive analysis, Buy Now –

About Fact.MR

Market research and consulting agency with a difference! That’s why 80% of fortune 1,000 companies trust us for making their most critical decisions. We have offices in us and dublin, whereas our global headquarter is in dubai. While our experienced consultants employ the latest technologies to extract hard-to-find insights, we believe our usp is the trust clients have on our expertise. Spanning a wide range – from automotive & industry 4.0 to healthcare & retail, our coverage is expansive, but we ensure even the most niche categories are analyzed. Reach out to us with your goals, and we’ll be an able research partner.


US Sales Office:
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Tel: +1 (628) 251-1583

Corporate Headquarter:
Unit No: AU-01-H Gold Tower (AU),
Plot No: JLT-PH1-I3A,
Jumeirah Lakes Towers,
Dubai, United Arab Emirates
Visit Our Website:


Matched content

Editor’s pick

Express Press Release Distribution